28/10/2021
PREFER’s proposals have been described by the EMA as a “comprehensive reference document for planning and conducting patient preference studies’’
Site Search
Site Search
Displaying results 41 - 50 of 503
01/07/2025
PROMINENT and AD-RIDDLE, two projects focusing on Alzheimer’s disease, are channelling health economics to ensure that new therapies and diagnostic methods for Alzheimer’s disease...
New Drugs for Bad Bugs
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
Methods for systematic next generation oncology biomarker development
18/09/2023
Following surgery to remove a tumour, blood tests could help to identify which patients really need further treatment, and which don’t.
Models of patient engagement for Alzheimer’s disease
Incorporating real-life clinical data into drug development
27/07/2023
The topics contribute to key EU policies such as the European Green Deal and the '3Rs' goals of replacing, reducing and refining the use of animals in research.
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
